|
|
|
| home > pmps > summer 2003 > sealing technology for active pharmaceutical ingredients manufacture |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
New developments in perfluoroelastomers are setting the standard for sealing in the manufacture and storage of active pharmaceutical ingredients. This article reviews the growing popularity of these elastomers and their application in total containment systems.
Primary pharmaceutical manufacturers are faced with a problem - how to handle active pharmaceutical ingredients (APIs) and intermediates without risk to the health of their workers arising from processing leaks or breaches in containment during manufacture? Moreover, to meet good manufacturing practice (GMP) regulations for API manufacture, manufacturing operations should not compromise API integrity through poor hygiene standards and cross contamination. To overcome these issues seals are used in pumps, valves and pipe work on the plant and in intermediate bulk containers (IBCs) used for the transportation of raw materials and intermediates.
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
Paediatric Clinical Trials
21-22 March 2012, Copthorne Tara Hotel, London, United Kingdom
Designing accurate and safe paediatric formulations is one of the topics being discussed at SMi’s Paediatric Clinical Trials held on 21st & 22nd March 2012
More info >> |
|
 |
News and Press Releases |
 |
Prism Ideas and dMetrics Launch Pioneering Service Analysing Patient–Reported Action, Behaviours and Outcomes with Social Media
Prism Ideas, the multi-national medical marketing and drug development consultants, today announced its collaboration with dMetrics, experts in identifying decisions made by millions of patients online, to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms and response to treatment.
More info >> |
|
|
